notice_summary_saf.revenue.

notice_summary_saf.eps, beating the estimate of USD -1.02.

notice_summary_saf.ebit.

The provided reference, a Form 8-K filing, indicates that Q32 Bio Inc. announced its financial results for the quarter ended June 30, 2026, and provided a corporate update on August 5, 2026. However, the specific financial and operational metrics, including segment revenue, net income, gross margin, operating profit, operating margin, operating costs, cash flow, and any company-specific indicators, as well as any outlook or guidance, are not detailed within this document. These details were made available in a press release furnished as Exhibit 99.1 to the Current Report on Form 8-K, which is not included in the provided reference for analysis.